ArticleCancer gene therapy2013

An HDAC inhibitor enhances cancer therapeutic efficiency of RNA polymerase III promoter-driven IDO shRNA.

M-C Yen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.